These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 6341443)

  • 21. Possible involvement of endogenous opioids in beta-cell hyperresponsiveness in human obesity.
    Vettor R; Martini C; Cestaro S; Manno M; Sicolo N; Federspil G
    Int J Obes; 1989; 13(4):425-32. PubMed ID: 2529225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-endorphin inhibits insulin secretion from isolated pancreatic islets.
    Schleicher RL
    Endocrinology; 1989 Mar; 124(3):1254-8. PubMed ID: 2521821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet lysosomal enzyme activities and glucose-induced insulin secretion: effects of mannoheptulose, 2-deoxyglucose and clonidine.
    Salehi AA; Lundquist I
    Pharmacology; 1993; 46(3):155-63. PubMed ID: 8441762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endogenous opiates modulate insulin secretion in flushing noninsulin-dependent diabetics.
    Mason JS; Heber D
    J Clin Endocrinol Metab; 1982 Apr; 54(4):693-7. PubMed ID: 7037812
    [No Abstract]   [Full Text] [Related]  

  • 25. Failure of naloxone to reduce clonidine-induced changes in blood pressure, heart rate and sympathetic nerve firing in cats.
    Shropshire AT; Wendt RL
    J Pharmacol Exp Ther; 1983 Mar; 224(3):494-500. PubMed ID: 6827474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreastatin modulates glucose-stimulated insulin secretion from the perfused rat pancreas.
    Ahrén B; Bertrand G; Roye M; Ribes G
    Acta Physiol Scand; 1996 Sep; 158(1):63-70. PubMed ID: 8876749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Naloxone effects on post-prandial glucose, insulin and C-peptide levels in obese subjects.
    De Marinis L; Mancini A; De Luca AM; Fiumara C; Zuppi P; Sammartano L; Valle D
    Diabetes Res; 1993; 23(2):83-91. PubMed ID: 7712683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial blockade by naloxone of clonidine-induced increase in plasma growth hormone in hypertensive patients.
    Bramnert M; Hökfelt B
    J Clin Endocrinol Metab; 1984 Feb; 58(2):374-7. PubMed ID: 6319449
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of clonidine on glucose, insulin and glucagon responses to a protein meal in type 2 diabetics.
    Ferlito S; Indelicato G; Di Vincenzo S; Del Campo F; La Vignera A; Fichera C
    J Endocrinol Invest; 1985 Jun; 8(3):185-7. PubMed ID: 3897355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hemodynamic effects of naloxone during clonidine treatment of patients with essential hypertension].
    Varga K; Kapocsi J; Juhász I; Kunos G; Farsang C
    Orv Hetil; 1983 Apr; 124(17):991-5. PubMed ID: 6346221
    [No Abstract]   [Full Text] [Related]  

  • 32. Possible role of an endogenous opiate in the cardiovascular effects of central alpha adrenoceptor stimulation in spontaneously hypertensive rats.
    Farsang C; Ramirez-Gonzalez MD; Mucci L; Kunos G
    J Pharmacol Exp Ther; 1980 Jul; 214(1):203-8. PubMed ID: 6248627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Naloxone does not affect the cardiovascular, sedative or neurohormonal effects of clonidine in normal and hypertensive man.
    Mathias CJ; da Costa DF; Cleary JC; Peart S
    J Hypertens Suppl; 1985 Dec; 3(4):S77-9. PubMed ID: 3007707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the effect of insulin hypoglycemia and clonidine on secretion of growth hormone, cortisol and beta-endorphin in children and adolescents.
    Gil-Ad I; Topper E; Bar-Yoseph J; Mamet R; Laron Z
    Isr J Med Sci; 1985 Nov; 21(11):912-4. PubMed ID: 2934351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Endogenous opiate modulators of insulin secretion in the obese].
    Satta MA; Maussier ML; Scoppola A; Menini E; Liberale I; Lio S; Monaco F; Roche J
    C R Seances Soc Biol Fil; 1988; 182(6):538-43. PubMed ID: 2978011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apparent pA2 estimates for an antinociceptive receptor.
    Parale MP; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):59-67. PubMed ID: 2862851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of the putative endogenous imidazoline receptor ligand, clonidine-displacing substance, on insulin secretion from rat and human islets of Langerhans.
    Chan SL; Atlas D; James RF; Morgan NG
    Br J Pharmacol; 1997 Mar; 120(5):926-32. PubMed ID: 9138700
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of interaction between 2-Br-alpha-ergocriptine (CB 154) and naloxone on the control of insulin secretion in normal men].
    Ghisoli E; Benfenati F; Meringolo D; Vecchi P; Zampa GA
    Boll Soc Ital Biol Sper; 1980 Jun; 56(12):1215-21. PubMed ID: 7006632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Failure of naloxone to modify the inhibitory effect of clonidine on insulin secretion.
    Massara F; Limone P; Tagliabue M; Molinatti GM
    J Endocrinol Invest; 1983 Feb; 6(1):67-8. PubMed ID: 6341443
    [No Abstract]   [Full Text] [Related]  

  • 40. Neuroendocrine control of basal insulin secretion in man: a study with bromocriptine, clonidine and naloxone.
    Zampa GA; Benfenati F; Ghisoli E; Corbucci G; Vecchi P; Zini I; Battistini N; Agnati LF
    J Endocrinol Invest; 1981; 4(4):423-9. PubMed ID: 7037921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.